Litcius/Paper detail

Developing a cosmetic series: Results from the <scp>ESSCA</scp> network, 2009‐2018

E. W. HORTON, Wolfgang Uter, Johannes Geier, Barbara Ballmer‐Weber, Andrea Bauer, Andreas J. Bircher, Heinrich Dickel, Ana M. Giménez‐Arnau, Margarida Gonçalo, Swen Malte John, Vera Mahler, Marie L. A. Schuttelaar, Dagmar Simon, J. Sánchez‐Pérez, Thomas Rustemeyer, Elke Weißhaar, Mark Wilkinson

2020Contact Dermatitis21 citationsDOIOpen Access PDF

Abstract

BACKGROUND: There is considerable variability across European patch test centres as to which allergens are included in local and national cosmetics series. OBJECTIVES: To propose a standardized, evidence-based cosmetic series for Europe based on up-to-date analysis of relevant contact allergens. METHODS: We collated data from the European Surveillance System on Contact Allergies (ESSCA) from 2009 to 2018 to determine which cosmetic allergens produce a high yield of contact allergy. Contact allergens with a prevalence of >0.3% that were considered relevant were included. Rare contact allergens were excluded if deemed no longer relevant or added to a supplemental cosmetic series for further analysis. RESULTS: Sensitization prevalences of 39 cosmetic contact allergens were tabulated. Thirty of these allergens yielded >0.3% positive reactions and are therefore included in our proposed European cosmetic series. Six were considered no longer relevant and therefore excluded. Three were included in a supplementary European cosmetic series. An additional nine allergens were included in either the core or supplemental European cosmetic series following literature review. CONCLUSION: We have derived a potential European cosmetic series based upon the above methods. This will require ongoing investigation based upon the changing exposure profiles of cosmetic allergens as well as new and evolving substances.

Topics & Concepts

CosmeticsContact allergyMedicineAllergyDermatologyAllergic contact dermatitisContact dermatitisAllergenPatch testPatch testingImmunologyPathologyContact Dermatitis and AllergiesAllergic Rhinitis and SensitizationAdvancements in Transdermal Drug Delivery
Developing a cosmetic series: Results from the <scp>ESSCA</scp> network, 2009‐2018 | Litcius